On July 11th, the "2023 Beijing International Life and Health Industry Cross-border Expo, Life and Health Innovators Annual Conference" was officially opened at the China International Exhibition Center in Beijing. With the theme of "4D Rules of Innovation Track", the branch ceremony, “Life and Health Innovators Annual Conference" organized by SiqiQuan, was launched there simultaneously.

Summer XIA, CEO of Hasten Biopharmaceutical Co., Ltd., was awarded the honorary title of "2023 Life and Health Innovation Award" due to his efforts in leading Hasten to actively fulfill its social responsibilities, help upstream and downstream enterprises grow through innovative business models, and contribute to the construction of "Healthy China 2030". This has been the second time for Summer winning this honorable award within two successive years at the Innovators Annual Conference.

During the conference, Summer XIA was also invited to deliver a speech entitled "Focus on Chronic Disease and Critical Care Platform – Being the Companions in the Construction of High-quality and Efficient Medical Systems” and expressed significant insights during the roundtable discussion.

"For start-ups, innovation is the core competitiveness.” Said by Summer XIA, “Hasten has achieved a series of milestones in the past year relying on our innovative commercialization model, which also proves our commitments to meet clinical and patient’s unmet needs at the chronic and critical care platform. In the future, we will continue to joint hands with more partners, via consistent exploring, to inject unique strengths to the optimization and upgrading for the whole healthcare industry. ”